Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Westlake Chemical Partners (WLKP) over the last 13 years, with Q3 2025 value amounting to -$951000.0.

  • Westlake Chemical Partners' Change in Receivables fell 15928.93% to -$951000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year increase of 35845.67%. This contributed to the annual value of -$25.7 million for FY2024, which is 583.22% up from last year.
  • Latest data reveals that Westlake Chemical Partners reported Change in Receivables of -$951000.0 as of Q3 2025, which was down 15928.93% from $37.9 million recorded in Q2 2025.
  • Over the past 5 years, Westlake Chemical Partners' Change in Receivables peaked at $88.0 million during Q4 2021, and registered a low of -$61.0 million during Q1 2021.
  • Moreover, its 5-year median value for Change in Receivables was -$951000.0 (2025), whereas its average is -$3.0 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 235646.69% in 2021, then tumbled by 289618.72% in 2024.
  • Over the past 5 years, Westlake Chemical Partners' Change in Receivables (Quarter) stood at $88.0 million in 2021, then crashed by 106.45% to -$5.7 million in 2022, then surged by 87.67% to -$700000.0 in 2023, then plummeted by 2586.29% to -$18.8 million in 2024, then surged by 94.94% to -$951000.0 in 2025.
  • Its Change in Receivables stands at -$951000.0 for Q3 2025, versus $37.9 million for Q2 2025 and $1.6 million for Q1 2025.